SpeechPathology.com Phone: 800-242-5183


EDU Healthcare Opportunities

Treatment Options for Adductor Spasmodic Dysphonia

George Charpied, M.A.,CCC-SLP

March 2, 2009

Share:

Question

What are the suggested treatment methods for patients with adductor spasmodic dysphonia, 2 weeks post botox injection?

Answer

Adductor spasmodic dysphonia, the more common form of laryngeal dystonia, is typically treated today with two therapeutic modalities, medically and behaviorally. Although both interventions provide some measure of relief from the symptoms of adductor spasmodic dysphonia, to date there is no cure. Adductor spasmodic dysphonia is a devastating voice disorder.

Spasmodic dysphonia, means spastic-like voice disorder. It isn't a true spastic motor disorder as descending cortical inhibition remains present, though faulty. At one time spasmodic dysphonia was thought to be a hysterical or functional vocal disorder. When first described in 1871 it was called 'nervous hoarseness' (Aronson and Hartman, 1981, JSHR, 46:52). But it is clear now that included in its pathophysiology is familial genetic predispositions (DYT allele, and others). Spasmodic dysphonia is thought to originate from some presently unknown derangement of the basal ganglia, as do a number of other motor disorders (i.e., Parkinson's disease). It is interesting that those motor disorders manifesting tremor as a feature of their pathology, also have basal ganglia origins (Brown and Simonson, 1963, Neurology, 2:520). Spasmodic dysphonia has been shown to have vocal tremor in 66% those diagnosed (Charpied and Grillone, 1997; unpublished data). Typical features of the dysphonia voice are the strain-strangle, associated excessive tension and respiratory exertion, and voice breaks in speech but not in vegetative tasks.

Electromyographic data seem to indicate that vocal strain represented selective hyperactivity of the adductor musculature, the lateral cricoarytenoid (LCA), with abnormal resting electromyographic levels in the posterior cricoarytenoid, thyroarytenoid (TA) and cricoarytenoid muscles (Cyrus, et al, Otolaryngology-HNS, 2001, 124:23). Thus, electromyographic evidence appears to argue for imbalance between the adductors and abductors favoring the adductors. These data indicate that an excessive adduction, LCA activity, and shortening of the vocal folds, TA activity, during phonation results in strained closure leading to significantly increased subglottal pressure.

Of the two treatment modalities, the medical injection of the clostridium bacterial toxin, Botulinum, provides the greatest relief to patients, although there is great individual variation. Within one to three weeks after injection patients report an absence of the strain-strangle, a decrease in the effortful, broken voice, and a decrease in their sense of dread when speaking events present themselves. Side effects of cough or choke at mealtimes and breathiness pass, usually without complication. In some patients the presence of tremor becomes more noticeable after injection. Hence, the behavioral mode of intervention for adductor spasmodic dysphonia, speech therapy, would have little efficacy immediately after the injection effect has begun. Where speech therapy has its greatest value is in teaching patients who do not go through injection therapy or are in-between injections to manage the symptoms of the disorder with proper compensatory strategies. These include relaxation techniques, use of diaphragmatic breathing and easy onset tone production, reduced number of words per utterance, with the goals of reducing both excessive adduction and increased subglottal pressure. Sometimes, slight pitch elevation for automatic responses and use of vegetative gestures also help as 'starters' of clearer vocalizations.

Mr. Charpied is the Director of the Department of Speech Pathology, in the Department of Otolaryngology - Head and Neck Surgery, with the University Rochester's School of Medicine and Dentistry and Strong Memorial Hospital. A clinically certified Speech Pathologist who specializes in voice and swallowing, Mr. Charpied has developed techniques and manuals on the diagnosis, treatment and management of voice and swallowing disorders. He teaches at Nazareth College, as well in the ENT resident program. His research interests include anatomy of the larynx, quantification of laryngeal function through image analysis, and the use of computers as a clinical tool. Besides publications and numerous abstracts, Mr. Charpied's introductory text for Speech Pathology students, Anatomic and Physiologic Elements of Human Communication," has been submitted for publication. He is currently completing a text titled, "Neurologic Basis of Human Communicative Behavior."


George Charpied, M.A.,CCC-SLP


Related Courses

20Q: Induced Laryngeal Obstruction - An Overview for Speech-Language Pathologists
Presented by Robert Brinton Fujiki, PhD, CCC-SLP
Text

Presenter

Robert Brinton Fujiki, PhD, CCC-SLP
Course: #10761Level: Intermediate1 Hour
  'Very informative!'   Read Reviews
The nature of induced laryngeal obstruction, including comorbidities and causes, and the speech-language pathologist’s role in evaluation and treatment of this disorder are described in this course. Current diagnostic and treatment practices and research updates pertaining to the condition are discussed.

20Q: Evaluation and Treatment of Speech/Resonance Disorders and Velopharyngeal Dysfunction
Presented by Ann W. Kummer, PhD, CCC-SLP
Text

Presenter

Ann W. Kummer, PhD, CCC-SLP
Course: #8729Level: Intermediate1 Hour
  'The course was informative as far as assessment and evaluation, though would have liked to see more treatment techniques post surgery'   Read Reviews
Children with speech and resonance disorders (hypernasality, hyponasality, and cul-de-sac resonance) and/or nasal emission present challenges for speech-language pathologists (SLPs) in all settings. This article will help participants to recognize resonance disorders and the characteristics of velopharyngeal dysfunction, and provide appropriate management.

Chronic Cough: Evaluation
Presented by Lauren Fay, MS, CCC-SLP
Video

Presenter

Lauren Fay, MS, CCC-SLP
Course: #10793Level: Introductory1 Hour
  'This is a new topic within the communication disorders world, since I graduated from college some years ago'   Read Reviews
This is Part 1 of a 2-part series. Chronic cough affects millions of people per year, and SLPs can be an integral part of evaluation and management of this disorder. Characteristics of chronic cough and its impact on quality of life are discussed in this course. In addition, SLP evaluation of chronic cough to identify candidates for voice therapy management is described in the context of medical evaluation and management.

MCI/Dementia: Writing Caregiver Education into Clients' Plans of Care
Presented by Allison Gallaher, MS, CCC-SLP
Video

Presenter

Allison Gallaher, MS, CCC-SLP
Course: #10798Level: Introductory1 Hour
  'The case studies with goal examples were very helpful'   Read Reviews
This course addresses the importance and methodology of writing goals that are family-centered in order to improve the outcomes of patients with mild cognitive impairment (MCI) and dementia. The addition of Caregiver Education to the 2024 Current Procedural Terminology (CPT) codes is also discussed.

Laryngectomy Basics: An Introduction to Voice and Pulmonary Changes
Presented by Samantha Jones, MA, CCC-SLP
Video

Presenter

Samantha Jones, MA, CCC-SLP
Course: #10299Level: Introductory1 Hour
  'Great Presenter, well organized'   Read Reviews
Basic clinical management skills related to pulmonary function and communication after a total laryngectomy are described in this course. Information about medical/surgical treatments, anatomic and physiologic changes, communication options, and pulmonary rehabilitation management is provided.

Our site uses cookies to improve your experience. By using our site, you agree to our Privacy Policy.